These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15532190)

  • 1. [The genetics HIV cohort of the Swiss HIV Cohort Study--facing the new challenges in medicine].
    Telenti A; Furrer H
    Ther Umsch; 2004 Oct; 61(10):613-8. PubMed ID: 15532190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study.
    Ledergerber B; Cavassini M; Battegay M; Bernasconi E; Vernazza P; Hirschel B; Furrer H; Rickenbach M; Weber R;
    HIV Med; 2011 May; 12(5):279-88. PubMed ID: 20955356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Opportunistic diseases in HIV infection].
    Furrer H
    Ther Umsch; 2004 Oct; 61(10):625-30. PubMed ID: 15532192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of regimen change due to drug toxicity among a cohort of South Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment.
    Sivadasan A; Abraham OC; Rupali P; Pulimood SA; Rajan J; Rajkumar S; Zachariah A; Kannangai R; Kandathil AJ; Sridharan G; Mathai D
    J Assoc Physicians India; 2009 May; 57():384-8. PubMed ID: 19634284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early participation in an HIV cohort study slows disease progression and improves survival. The Swiss HIV Cohort Study.
    Battegay M; Wirz M; Steuerwald MH; Egger M
    J Intern Med; 1998 Dec; 244(6):479-87. PubMed ID: 9893101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000.
    Sudre P; Rickenbach M; Taffé P; Janin P; Volkart AC; Francioli P;
    Schweiz Med Wochenschr; 2000 Oct; 130(41):1493-500. PubMed ID: 11075414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus in an aging population, a complication of success.
    Kirk JB; Goetz MB
    J Am Geriatr Soc; 2009 Nov; 57(11):2129-38. PubMed ID: 19793157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort.
    Taffé P; May M;
    Stat Med; 2008 Oct; 27(23):4835-53. PubMed ID: 18444229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort profile: the Swiss HIV Cohort study.
    ; Schoeni-Affolter F; Ledergerber B; Rickenbach M; Rudin C; Günthard HF; Telenti A; Furrer H; Yerly S; Francioli P
    Int J Epidemiol; 2010 Oct; 39(5):1179-89. PubMed ID: 19948780
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification.
    Keiser O; Fellay J; Opravil M; Hirsch HH; Hirschel B; Bernasconi E; Vernazza PL; Rickenbach M; Telenti A; Furrer H;
    Antivir Ther; 2007; 12(8):1157-64. PubMed ID: 18240856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentations of severe cutaneous drug reactions in HIV-infected Africans.
    Lehloenya RJ; Kgokolo M
    Dermatol Clin; 2014 Apr; 32(2):227-35. PubMed ID: 24680008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
    Mocroft A; Ledergerber B; Zilmer K; Kirk O; Hirschel B; Viard JP; Reiss P; Francioli P; Lazzarin A; Machala L; Phillips AN; Lundgren JD;
    AIDS; 2007 Sep; 21(14):1867-75. PubMed ID: 17721094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.